NDC 0378-6678

Sunitinib Malate

Sunitinib Malate

Sunitinib Malate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Sunitinib Malate.

Product ID0378-6678_4dbfcc02-dacc-4f0c-9f41-095783b68e27
NDC0378-6678
Product TypeHuman Prescription Drug
Proprietary NameSunitinib Malate
Generic NameSunitinib Malate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-01-04
Marketing CategoryANDA /
Application NumberANDA201275
Labeler NameMylan Pharmaceuticals Inc.
Substance NameSUNITINIB MALATE
Active Ingredient Strength13 mg/1
Pharm ClassesProtein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0378-6678-28

28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6678-28)
Marketing Start Date2022-01-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sunitinib Malate" or generic name "Sunitinib Malate"

NDCBrand NameGeneric Name
0093-8199Sunitinib MalateSunitinib Malate
0093-8224Sunitinib MalateSunitinib Malate
0093-8229Sunitinib MalateSunitinib Malate
0093-8231Sunitinib MalateSunitinib Malate
0378-6678Sunitinib Malatesunitinib malate
0378-6679Sunitinib Malatesunitinib malate
0378-6680Sunitinib Malatesunitinib malate
0378-6681Sunitinib Malatesunitinib malate
16714-676Sunitinib malateSunitinib malate
16714-677Sunitinib malateSunitinib malate
0069-0550SUTENTSunitinib malate
0069-0770SUTENTSunitinib malate
0069-0830SUTENTSunitinib malate
0069-0980SUTENTSunitinib malate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.